419 related articles for article (PubMed ID: 29369348)
1. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P
Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study.
Trinka E; Rocamora R; Chaves J; Moreira J; Ikedo F; Soares-da-Silva P;
Epilepsia; 2020 Oct; 61(10):2129-2141. PubMed ID: 32944934
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
Pazdera L; Sperling MR; Harvey JH; Sam MC; Strom LA; Blum D; Grinnell T; Cheng H
Epilepsia; 2018 Mar; 59(3):704-714. PubMed ID: 29450890
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America.
Sperling MR; Harvey J; Grinnell T; Cheng H; Blum D;
Epilepsia; 2015 Apr; 56(4):546-55. PubMed ID: 25689448
[TBL] [Abstract][Full Text] [Related]
6. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Ben-Menachem E; Gabbai AA; Hufnagel A; Maia J; Almeida L; Soares-da-Silva P
Epilepsy Res; 2010 May; 89(2-3):278-85. PubMed ID: 20299189
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
Baulac M; Patten A; Giorgi L
Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
[TBL] [Abstract][Full Text] [Related]
10. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
Elger C; Bialer M; Cramer JA; Maia J; Almeida L; Soares-da-Silva P
Epilepsia; 2007 Mar; 48(3):497-504. PubMed ID: 17319919
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Ben-Menachem E; Grebe HP; Terada K; Jensen L; Li T; De Backer M; Steiniger-Brach B; Gasalla T; Brock M; Biton V
Epilepsia; 2019 Dec; 60(12):2437-2447. PubMed ID: 31755090
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton V; Rogin JB; Krauss G; Abou-Khalil B; Rocha JF; Moreira J; Gama H; Trinka E; Elger CE; Cheng H; Grinnell T; Blum D;
Epilepsy Behav; 2017 Jul; 72():127-134. PubMed ID: 28575761
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
Gil-Nagel A; Lopes-Lima J; Almeida L; Maia J; Soares-da-Silva P;
Acta Neurol Scand; 2009 Nov; 120(5):281-7. PubMed ID: 19832771
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
Schmitz B; Dimova S; Zhang Y; Chellun D; De Backer M; Gasalla T
Epilepsy Res; 2020 Jan; 159():106220. PubMed ID: 31812127
[TBL] [Abstract][Full Text] [Related]
15. Eslicarbazepine Acetate: A Review in Focal-Onset Seizures.
Heo YA
CNS Drugs; 2020 Sep; 34(9):989-1000. PubMed ID: 32737793
[TBL] [Abstract][Full Text] [Related]
16. Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
Galiana GL; Gauthier AC; Mattson RH
Drugs R D; 2017 Sep; 17(3):329-339. PubMed ID: 28741150
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.
Jacobson MP; Pazdera L; Bhatia P; Grinnell T; Cheng H; Blum D;
BMC Neurol; 2015 Mar; 15():46. PubMed ID: 25880756
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with eslicarbazepine acetate in adults with sub-analysis of elderly.
Nielsen MK; Petrenaite V; Andersen NB
Seizure; 2017 Dec; 53():94-99. PubMed ID: 29172139
[TBL] [Abstract][Full Text] [Related]
19. Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures.
Keating GM
CNS Drugs; 2014 Jul; 28(7):583-600. PubMed ID: 24972948
[TBL] [Abstract][Full Text] [Related]
20. Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.
Shirley M; Dhillon S
Drugs; 2016 Apr; 76(6):707-17. PubMed ID: 27055527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]